PL374487A1 - Kompozycje farmaceutyczne o kontrolowanym uwalnianiu zawierające alginian sodowy i alginian sodowo-wapniowy - Google Patents

Kompozycje farmaceutyczne o kontrolowanym uwalnianiu zawierające alginian sodowy i alginian sodowo-wapniowy

Info

Publication number
PL374487A1
PL374487A1 PL03374487A PL37448703A PL374487A1 PL 374487 A1 PL374487 A1 PL 374487A1 PL 03374487 A PL03374487 A PL 03374487A PL 37448703 A PL37448703 A PL 37448703A PL 374487 A1 PL374487 A1 PL 374487A1
Authority
PL
Poland
Prior art keywords
alginate
sodium
pharmaceutical compositions
controlled release
compositions containing
Prior art date
Application number
PL03374487A
Other languages
English (en)
Other versions
PL208591B1 (pl
Inventor
Robert Pisek
Andrejka Kramar
Franc Vrecer
Maja Kincl
Marjanca Breznik
Original Assignee
Krka, Tovarna Zdravil, D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, Tovarna Zdravil, D.D. filed Critical Krka, Tovarna Zdravil, D.D.
Publication of PL374487A1 publication Critical patent/PL374487A1/pl
Publication of PL208591B1 publication Critical patent/PL208591B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL374487A 2002-10-08 2003-10-06 Kompozycje farmaceutyczne o kontrolowanym uwalnianiu zawierające alginian sodowy i alginian sodowo-wapniowy PL208591B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200200242A SI21300A (sl) 2002-10-08 2002-10-08 Farmacevtske formulacije z alginati

Publications (2)

Publication Number Publication Date
PL374487A1 true PL374487A1 (pl) 2005-10-31
PL208591B1 PL208591B1 (pl) 2011-05-31

Family

ID=32091983

Family Applications (1)

Application Number Title Priority Date Filing Date
PL374487A PL208591B1 (pl) 2002-10-08 2003-10-06 Kompozycje farmaceutyczne o kontrolowanym uwalnianiu zawierające alginian sodowy i alginian sodowo-wapniowy

Country Status (9)

Country Link
EP (1) EP1560568B1 (pl)
AU (1) AU2003273212A1 (pl)
EA (1) EA007488B1 (pl)
HR (1) HRP20050312B1 (pl)
PL (1) PL208591B1 (pl)
RS (1) RS52818B (pl)
SI (2) SI21300A (pl)
UA (1) UA80990C2 (pl)
WO (1) WO2004032904A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR122018068450B8 (pt) 2004-10-12 2021-07-27 Fmc Biopolymer As dispositivo implantável compreendendo gel de alginato
US8809521B2 (en) 2007-08-28 2014-08-19 Fmc Biopolymer As Delayed self-gelling alginate systems and uses thereof
CN108853039B (zh) * 2018-08-07 2021-03-09 河北君临药业有限公司 一种克拉霉素分散片及其生产工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE66143T1 (de) * 1985-01-11 1991-08-15 Abbott Lab Feste zubereitung mit langsamer freisetzung.
EP0275336A1 (de) * 1987-01-20 1988-07-27 Knoll Ag Arzneimittelzubereitung mit protahierender Wirkung
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
SK282427B6 (sk) * 1997-06-11 2002-01-07 Abbott Laboratories Pevná farmaceutická kompozícia s riadeným uvoľňovaním

Also Published As

Publication number Publication date
RS52818B (sr) 2013-10-31
WO2004032904A1 (en) 2004-04-22
SI1560568T1 (sl) 2014-08-29
UA80990C2 (en) 2007-11-26
HRP20050312A2 (en) 2006-02-28
EA200500613A1 (ru) 2005-10-27
RS20050276A (en) 2007-06-04
PL208591B1 (pl) 2011-05-31
HRP20050312B1 (hr) 2014-09-26
EP1560568B1 (en) 2014-03-26
EP1560568A1 (en) 2005-08-10
EA007488B1 (ru) 2006-10-27
AU2003273212A1 (en) 2004-05-04
SI21300A (sl) 2004-04-30

Similar Documents

Publication Publication Date Title
IL160117A0 (en) Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
HUP0400384A3 (en) Benzamidine derivative and pharmaceutical compositions containing them and their use
HUS1400025I1 (hu) Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek
IL164987A0 (en) Proline derivatives and pharmaceutical compositions containing
HUP0303325A3 (en) Pharmaceutical salts and pharmaceutical compositions containing them
AU2003291103A8 (en) Pharmaceutical composition
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
EP1424994A4 (en) PREPARATION OF A SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION
EG24479A (en) Modified release pharmaceutical formulation
EP1425019A4 (en) PHARMACEUTICAL COMPOSITION
SI1458377T1 (sl) Tegaserodovi farmacevtski sestavki
HRP20041079A2 (en) Novel perindopril salt and pharmaceutical compositions containing same
AU2003250372A8 (en) Pharmaceutical composition
IL176077A0 (en) 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
PL376840A1 (pl) Kompozycja farmaceutyczna o przedłużonym uwalnianiu
IL165069A0 (en) Immediate release pharmaceutical formulation
EP1501352A4 (en) METHOD AND COMPOSITIONS FOR PROTRACTED ACTIVE SUBSTANCE
EP1404301A4 (en) PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE, STABLE, CONTAINING PRAVASTATIN
SI1560568T1 (sl) Farmacevtski sestavki z nadzorovanim sproščanjem, ki vsebujejo natrijev alginat in natrijev-kalcijev alginat
HK1081451A1 (en) Medicinal composition
HK1062274A1 (en) Medicinal composition
AU2003258772A8 (en) Novel neutracetical and pharmaceutical compositions and their uses
AU2002236132A1 (en) Modified release oral pharmaceutical composition
EP1547593A4 (en) MEDICINAL COMPOSITION
AU2003300986A1 (en) An extended release pharmaceutical composition of phenytoin sodium